Molecular Modeling Studies of Peptide Drug Candidates against SARS

Authors: Zhang, Rui; Wei, Dong-Qing; Du, Qi-Shi; Chou, Kuo-Chen

Source: Medicinal Chemistry, Volume 2, Number 3, May 2006 , pp. 309-314(6)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

Price: $62.88 plus tax (Refund Policy)

Abstract:

Flexible alignment and docking studies were conducted for the three octapeptides, ATLQANEV, AVLQSGFR, and ATLQAIAS, that were cleavable by SARS-CoV Mpro. It has been observed that all pharmacophores of the three peptides overlap very well, and that ATLQANEV binds best with the receptor, followed by AVLQSGFR, and then ATLQAIAS. During the process of docking the octapeptides to the SARS enzyme, the residues of the catalytic dyad, i.e., His-41 and Cys-145 are actively involved in forming the hydrogen bonds, so is the center residue (Gln) of all the three octapeptides. The findings are fully consistent with experimental observations. The present studies suggest that the octapeptides ATLQANEV and ATLQAIAS, like AVLQSGFR, might also be the good starting points for designing potential drugs against SARS.

Keywords: SARS; CoV Mpro; protease inhibitor; cleavable peptides; autodock; distorted key theory; flexible alignment; binding free energy

Document Type: Research article

DOI: http://dx.doi.org/10.2174/157340606776930736

Affiliations: 1: Gordon Life Science Institute, 13784 Torrey Del Mar Drive, San Diego, CA 92130, USA.

Publication date: 2006-05-01